LUMETTI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.186
AS - Asia 3.607
EU - Europa 3.073
SA - Sud America 567
AF - Africa 55
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.050
SG - Singapore 1.145
CN - Cina 1.142
IT - Italia 841
GB - Regno Unito 746
HK - Hong Kong 466
BR - Brasile 460
SE - Svezia 359
DE - Germania 265
VN - Vietnam 233
FI - Finlandia 186
RU - Federazione Russa 169
TR - Turchia 114
IN - India 111
FR - Francia 109
ID - Indonesia 101
KR - Corea 92
UA - Ucraina 80
CA - Canada 71
BG - Bulgaria 53
JP - Giappone 46
MX - Messico 46
AR - Argentina 40
ES - Italia 40
NL - Olanda 40
PL - Polonia 34
AT - Austria 31
IE - Irlanda 26
ZA - Sudafrica 26
BD - Bangladesh 25
MY - Malesia 20
IR - Iran 17
BE - Belgio 16
IQ - Iraq 15
PE - Perù 15
NO - Norvegia 14
CZ - Repubblica Ceca 13
LT - Lituania 13
EC - Ecuador 12
PK - Pakistan 12
AU - Australia 11
CL - Cile 11
PY - Paraguay 10
TW - Taiwan 9
VE - Venezuela 9
EG - Egitto 8
RO - Romania 8
CH - Svizzera 6
CO - Colombia 6
IL - Israele 6
MA - Marocco 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
AL - Albania 4
BZ - Belize 4
EU - Europa 4
JO - Giordania 4
KZ - Kazakistan 4
RS - Serbia 4
TN - Tunisia 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
GR - Grecia 3
HU - Ungheria 3
KE - Kenya 3
NP - Nepal 3
SY - Repubblica araba siriana 3
BB - Barbados 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RE - Reunion 2
SR - Suriname 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
ET - Etiopia 1
GY - Guiana 1
JM - Giamaica 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MZ - Mozambico 1
NG - Nigeria 1
OM - Oman 1
Totale 13.500
Salva come PNG Salva come JPEG
Città #
Santa Clara 937
Singapore 724
Ashburn 587
Hong Kong 465
Fairfield 445
Southend 415
Chandler 414
Hefei 407
Woodbridge 251
London 191
Nyköping 190
Houston 188
Ann Arbor 180
San Jose 168
Seattle 161
Wilmington 152
Jacksonville 150
Beijing 147
Cambridge 135
Helsinki 128
Los Angeles 127
Dearborn 109
Modena 109
New York 105
Chicago 87
San Diego 87
Jakarta 86
Seoul 84
The Dalles 82
Ho Chi Minh City 72
Bologna 68
Milan 57
Princeton 56
Hanoi 55
Izmir 54
Shanghai 54
Sofia 53
São Paulo 49
Moscow 48
Atlanta 46
Munich 45
Parma 43
Bremen 39
Frankfurt am Main 37
Buffalo 36
Dallas 30
Salt Lake City 30
Rome 28
Tokyo 28
Warsaw 28
Denver 25
Eugene 25
Council Bluffs 24
Lappeenranta 24
Delhi 23
Guangzhou 23
Kent 23
Orem 23
Montreal 22
Stockholm 21
Valencia 21
New Delhi 20
Redondo Beach 20
Reggio Emilia 20
Toronto 20
Columbus 19
Florence 19
Redwood City 19
Dublin 17
Johannesburg 16
Ottawa 16
Turku 16
Boardman 15
Brussels 15
Ovada 15
Turin 15
Brooklyn 13
Chennai 13
Elk Grove Village 13
Lauterbourg 13
Lima 13
Mexico City 13
Paris 13
Phoenix 13
Querétaro 13
Rio de Janeiro 13
Ankara 12
Haiphong 12
Nuremberg 12
Poplar 12
San Francisco 12
Skien 12
Boston 11
Mumbai 11
Portsmouth 11
Vienna 11
Amsterdam 10
Antalya 10
Dong Ket 10
Belo Horizonte 9
Totale 9.068
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 362
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 297
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 296
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 292
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 290
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 285
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 283
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 267
APPLICATION OF CRITERIA FOR THE DIAGNOSIS OF “CLINICAL OSTEOPOROSIS ” IN A POPULATION OF POSTMENOPAUSAL WOMEN FROM EMILIA-ROMAGNA REGION 259
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 252
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 243
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 240
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 240
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 233
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 227
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 216
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 215
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 213
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 207
Osteomyelitis complicating scleroderma digital ulcers. 203
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 201
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 196
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 196
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 194
A SELF-ADMINISTERED QUESTIONNAIRE MAY ALLOW GENERAL PRACTITIONERS TO PERFORM A RAPID SCREENING TO IDENTIFY PATIENTS AT RISK FOR FRAGILITY FRACTURES AND TO ADDRESS THEM TO BONE METABOLISM SPECIALIZED CLINICAL CENTERS 192
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 189
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 186
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 178
Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study" 178
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 177
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 175
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 174
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 172
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 170
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE 170
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 169
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 169
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 169
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 165
Thu0349 autologous fat grafting in the treatment of patients with systemic sclerosis: current experience and future prospects 161
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 159
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 157
One-year clinical experience on the use of Nintedanib in Systemic Sclerosis 157
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 152
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 151
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 151
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 151
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 149
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 149
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study 144
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 143
PSYCHIATRIC DISORDERS IN RHEUMATOLOGY: EVALUATION OF A SCREENING PROTOCOL IN 100 HOSPITALIZED PATIENTS 141
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 139
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 138
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 134
KIENBOCK DISEASE IN A PATIENT WITH SSc: A CASE REPORT 134
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 131
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 127
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 121
Erratum: From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution (Dermatology Research and Practice (2018) 2018 (1284687) DOI: 10.1155/2018/1284687) 120
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 115
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 115
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 108
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 108
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 105
Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature 104
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 103
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 99
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 98
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 95
Infections of scleroderma digital ulcers: A single center cohort retrospective study 93
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 88
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 83
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 81
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSI 75
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 74
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study 72
FRI0651 Quantitative chest ct predicts 8-years-mortality and comorbidity in systemic sclerosis 72
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 72
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. 71
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 66
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study 59
First-­ line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-­ SIR registry 55
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 45
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 26
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 13
Comparative effectiveness of cycling versus swapping to UL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real- world multicenter study 12
Guselkumab effectiveness in real-world settings: Observations from an Italian multicentre study 10
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry. 6
Totale 13.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021595 0 0 0 0 0 0 142 138 53 110 109 43
2021/20221.160 31 45 86 100 47 88 42 91 150 95 243 142
2022/20231.261 157 147 89 114 127 160 51 119 177 19 51 50
2023/2024970 27 61 47 143 196 55 84 98 23 33 74 129
2024/20253.728 121 52 64 233 740 599 313 198 428 145 343 492
2025/20263.914 488 273 528 927 959 510 229 0 0 0 0 0
Totale 13.672